cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Evolus Inc
10 own
7 watching
Current Price
$11.46
$-0.04
(-0.35%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
566.81M
52-Week High
52-Week High
15.43300
52-Week Low
52-Week Low
7.07000
Average Volume
Average Volume
0.27M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization566.81M
icon52-Week High15.43300
icon52-Week Low7.07000
iconAverage Volume0.27M
iconDividend Yield--
iconP/E Ratio--
What does the Evolus Inc do?
N/A
Read More
How much money does Evolus Inc make?
News & Events about Evolus Inc.
Business Wire
10 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has commenced the commercial launch of Nuceiva (botulinum toxin type A) in Italy. The product is now available for direct order and delivery to customers. Nuceiva is approved by the European...
Business Wire
10 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced the completion of its Phase 2 clinical study evaluating an extra-strength dose for extended duration of Jeuveau (prabotulinumtoxinA-xvfs), its flagship...
Business Wire
11 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its first quarter 2023 financial results and provide a business update on Tuesday, May 9, 2023, after the U.S. financial...
Business Wire
1 year ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida. Event: Barclays...
Business Wire
1 year ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, has commenced the commercial launch of Nuceiva (botulinum toxin type A) in Germany and Austria, and is now available for direct order and delivery to customers...
Frequently Asked Questions
Frequently Asked Questions
What is Evolus Inc share price today?
plus_minus_icon
Can Indians buy Evolus Inc shares?
plus_minus_icon
How can I buy Evolus Inc shares from India?
plus_minus_icon
Can Fractional shares of Evolus Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Evolus Inc stocks?
plus_minus_icon
What is today’s traded volume of Evolus Inc?
plus_minus_icon
What is today’s market capitalisation of Evolus Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Evolus Inc?
plus_minus_icon
What percentage is Evolus Inc down from its 52-Week High?
plus_minus_icon
What percentage is Evolus Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.46
$-0.04
(-0.35%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ZENTALIS PHARMACEUTICALS INC
ZENTALIS PHARMACEUTICALS INC
$10.98
$-0.79 (-6.67 %)
TARSUS PHARMACEUTICALS INC
TARSUS PHARMACEUTICALS INC
$32.21
$-0.55 (-1.68 %)
POSEIDA THERAPEUTICS INC
POSEIDA THERAPEUTICS INC
$2.05
$-0.02 (-0.97 %)
PMV PHARMACEUTICALS INC
PMV PHARMACEUTICALS INC
$1.71
$0.02 (1.18 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
ZENTALIS PHARMACEUTICALS INC
ZENTALIS PHARMACEUTICALS INC
$10.98
$-0.79 (-6.67 %)
TARSUS PHARMACEUTICALS INC
TARSUS PHARMACEUTICALS INC
$32.21
$-0.55 (-1.68 %)
POSEIDA THERAPEUTICS INC
POSEIDA THERAPEUTICS INC
$2.05
$-0.02 (-0.97 %)
PMV PHARMACEUTICALS INC
PMV PHARMACEUTICALS INC
$1.71
$0.02 (1.18 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00